Learning curve of robotic-assisted splenic vessel-preserving spleen-preserving distal pancreatectomy by one single surgeon: a retrospective cohort study

BMC Surg. 2023 Dec 19;23(1):382. doi: 10.1186/s12893-023-02294-y.

Abstract

Aim: Splenic vessel-preserving spleen-preserving distal pancreatectomy (SVP-SPDP) has a lower risk of splenic infarction than the splenicvessel-sacrificing SPDP, but it is more technically demanding. Learning curve of robotic-assisted SVP-SPDP (RSVP-SPDP) remains unreported. This study sought to analyze the perioperative outcomes and learning curve of RSVP-SPDP by one single surgeon.

Methods: Seventy-four patients who were intended to receive RSVP-SPDP at the First Affiliated Hospital of Sun Yat-sen University between May 2015 and January 2023 were included. The learning curve were retrospectively analyzed by using cumulative sum (CUSUM) analyses.

Results: Sixty-two patients underwent RSVP-SPDP (spleen preservation rate: 83.8%). According to CUSUM curve, the operation time (median, 318 vs. 220 min; P < 0.001) and intraoperative blood loss (median, 50 vs. 50 mL; P = 0.012) was improved significantly after 16 cases. Blood transfusion rate (12.5% vs. 3.4%; P = 0.202), postoperative major morbidity rate (6.3% vs. 3.4%; P = 0.524), and postoperative length-of-stay (median, 10 vs. 8 days; P = 0.120) improved after 16 cases but did not reach statistical difference. None of the patients had splenic infarction or abscess postoperatively.

Conclusion: RSVP-SPDP was a safe and feasible approach for selected patients after learning curve. The improvement of operation time and intraoperative blood loss was achieved after 16 cases.

Keywords: Learning curve; Robotic-assisted surgery; Spleen-preserving distal pancreatectomy; Splenic vessels preservation.

MeSH terms

  • Blood Loss, Surgical
  • Humans
  • Laparoscopy*
  • Learning Curve
  • Pancreatectomy
  • Pancreatic Neoplasms* / surgery
  • Retrospective Studies
  • Robotic Surgical Procedures*
  • Splenic Artery / surgery
  • Splenic Infarction* / etiology
  • Splenic Infarction* / surgery
  • Surgeons*
  • Treatment Outcome

Substances

  • N-succinimidyl 3-(2-pyridyldithio)propionate